Novo posts worst monthly decline as Lilly extends lead
Novo Nordisk (NVO) has posted its worst-ever stock performance in February as its rival Eli Lilly (LLY) continues to...
Tag: LLY
Novo downgraded at J.P. Morgan as next-gen obesity drug trails Lilly’s Zepbound
J.P. Morgan downgraded Novo Nordisk (NVO) on Tuesday after the Danish drugmaker posted late-stage trial data indicating that...
Eli Lilly slips as Novo to cut list prices for GLP-1 drugs
Eli Lilly (LLY) shares turned lower in the premarket on Tuesday after its rival Novo Nordisk (NVO) announced plans to cut...
Lilly’s Zepbound gets FDA label expansion approval for KwikPen
Eli Lilly (LLY) said the U.S. FDA has approved a label expansion for Zepbound (tirzepatide) to include the four-dose...
Novo Nordisk stock tumbles as next-gen obesity shot underperforms Lilly’s tirzepatide
Novo Nordisk (NVO) shares fell nearly 11% in premarket trading Monday after the company’s next-generation obesity drug...
Pharmaceutical tariffs still in play despite Supreme Court ruling
Ongoing threats from President Trump to enact tariffs on pharmaceutical products imported into the United States could...
Sanofi sued by Texas AG for running kickback scheme for doctors
Texas Attorney General Ken Paxton (R) has filed a lawsuit against Sanofi (SNY), accusing the French pharma giant of...
Eli Lilly unveils long-term data on Omvoh for Crohn’s disease
Eli Lilly (LLY) said that data from a phase 3 open-label extension study indicated that its IL-23 antagonist Omvoh...
Lilly says Zepbound-containing regimen succeeded in a trial for psoriasis
Eli Lilly (LLY) announced on Wednesday that a late-stage trial designed to test a combination regimen containing its weight...
Eli Lilly in licensing deal with CSL for clazakizumab
Eli Lilly (LLY) will pay Australian biopharma CSL (CSLLY) $100M for a license to explore additional indications for the...